NEWS
September 26, 2011 | By Eryn Brown, Los Angeles Times / For the Booster Shots blog
A large number of the world's 300 million people with asthma -- as many as 40% -- don't respond to the inhalers their doctors prescribe to improve lung function. But doctors don't know how to predict which patients will benefit from glucocorticoid therapy (steroid inhalers) and which ones won't. But researchers at the Harvard Medical School have now located a genetic variation that may some day help physicians figure it out. The team's results, published Monday in the New England Journal of Medicine, used a genome-wide analysis of 118 trios (consisting of a child and his or her parents)
NEWS
September 26, 2011 | By Jeannine Stein, Los Angeles Times / For the Booster Shots blog
You've decided to help your health and the environment by riding your bike to work. Good for you! Sorry to have to deliver the bad news: you may be inhaling more soot. The amount might be more than twice as much as urban pedestrians, says a pilot study presented Sunday at the European Respiratory Society's Annual Congress . The study involved five cyclists who regularly biked to work and five pedestrians from London. They ranged in age from 18 to 40 and were healthy nonsmokers.
HEALTH
September 13, 2011 | By Melissa Healy, Los Angeles Times
Inhaling a concentrated cloud of insulin through the nose twice a day appears to slow — and in some cases reverse — symptoms of memory loss in people with early signs of Alzheimer's disease, a new pilot study has found. The study involved only 104 people and is considered very preliminary. But it suggests that a safe, simple and cheap measure that boosts flagging metabolism in key areas of the brain could hold off or possibly derail the progression of the devastating neurological disorder in its early stages.
NEWS
May 11, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
This post has been corrected. See note at bottom for details. Hey kids, coal power production and consumption are actually quite safe. In fact, coal power is, when you come right down to it, solar power. And one company, Peabody Energy, even wants to give free inhalers to families who live within 200 miles of a coal plant. Such are the statements made on a hoax website, CoalCares.org . The site is fairly convincing, promising to send custom asthma inhalers emblazoned with the likenesses of Dora the Explorer, Miley Cyrus and Justin Bieber.
NEWS
May 5, 2011 | By Marissa Cevallos, HealthKey
Asthma pills appear to work just as well as inhaled steroids at relieving asthma symptoms in real-life settings, researchers have found, apparently because people prefer swallowing a pill to sticking something up their nose. In one clinical trial, asthma sufferers who took as a first-line therapy the oral medications Singulair or Accolate , each a brand of leukotriene-receptor antagonists, reported as much symptom relief on a quality-of-life survey at two months as those who used an inhaled glucocorticoid, according to a new study published in the New England Journal of Medicine.
BUSINESS
February 11, 2011 | By Stephen Ceasar, Los Angeles Times
Mannkind Corp., the Valencia biotech firm, announced that it would lay off 41% of its workforce and focus on receiving regulatory approval for its long-delayed insulin inhaler being developed for people with diabetes. The company said it told 179 employees Thursday that they would be laid off by mid-April, reducing its workforce to 257 employees, according to documents filed with the Securities and Exchange Commission. In a phone call with industry analysts Thursday, billionaire founder and Chief Executive Alfred Mann said the company would retain the staffing needed to "support the path to approval" for the drug, named Afrezza, which the U.S. Food and Drug Administration declined to approve last month.